Records containing: Hypoparathyroidism
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2020-05-01Predicting Risk Factors of Postoperative Hypocalcemia After Total Thyroidectomy: is Safe Discharge Without Supplementation Possible?
-
CLINICAL_TRIALS study record update · 2020-04-09An Open-Label, Randomized, Crossover Study to Assess the Pharmacokinetic and Pharmacodynamic Profiles of Once Daily and Twice Daily Dose Regimens of Recombinant Human Parathyroid Hormone (rhPTH[1-84]) Administered Subcutaneously to Subjects With Hypoparathyroidism
-
CLINICAL_TRIALS study record update · 2019-12-12Effects of a Liquid Meal and Gut Hormones (GIP and GLP-2) on Bone Remodeling in Participants With Hypoparathyroidism (KS-4-HypoPT).
-
CLINICAL_TRIALS study record update · 2019-10-15Bi-daily Injection of Subcutaneous Teriparatide in Children With Hypoparathyroidism: Single-center Experience
-
CLINICAL_TRIALS study record update · 2019-08-06A Long-term Open-label Study Investigating the Safety and Tolerability of NPSP558, a Recombinant Human Parathyroid Hormone (rhPTH[1-84]), for the Treatment of Adults With Hypoparathyroidism - A Clinical Extension Study (RACE)
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2019-07-12A Phase 1, Open-label, Randomized, Cross-over Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of a Single Dose of rhPTH(1-84) Administered Subcutaneously in Japanese Healthy Subjects Compared With Matched Non-Hispanic, Caucasian Healthy Adult Subjects and to Assess Dose Proportionality of 3 Doses of rhPTH(1-84) in the Japanese Subjects
-
CLINICAL_TRIALS study record update · 2019-03-26An Evaluation of the Pharmacokinetics and Pharmacodynamics of Oral Parathyroid Hormone [PTH (1-34)] and NATPARA® in Patients With Hypoparathyroidism
-
CLINICAL_TRIALS study record update · 2019-01-08Effects of PTH Replacement on Bone in Hypoparathyroidism
-
CLINICAL_TRIALS study record update · 2018-05-02Study on Application of Suturing Parathyroid Markers in Thyroid Cancer Surgery
-
CLINICAL_TRIALS study record update · 2018-02-28Phase II Trial of Parathyroid Hormone for the Treatment of Hypoparathyroidism
-
CLINICAL_TRIALS study record update · 2018-02-19Burden of Illness and Disease Associated Emergencies in Chronic Hypoparathyroidism
-
CLINICAL_TRIALS study record update · 2017-10-27Corticosteroid Rhythms in Hypoparathyroid Patients
-
CLINICAL_TRIALS study record update · 2017-07-02Physiologic Regulation of FGF-23
-
CLINICAL_TRIALS study record update · 2015-12-15Treatment of Hypoparathyroidism With Synthetic Human Parathyroid Hormone 1-34
-
CLINICAL_TRIALS study record update · 2015-10-07A Pilot Study to Assess the Safety and Efficacy of Oral PTH (1-34) in the Treatment of Hypoparathyroidism
-
CLINICAL_TRIALS study record update · 2015-07-16Bone Properties in Hypoparathyroidism: Effects of PTH
-
CLINICAL_TRIALS study record update · 2015-03-31A Randomized, Two Phase, Adaptive Then Crossover Open-label, Study Comparing Amorphous Calcium Carbonate (ACC) Supplement Versus Commercially Available Crystalline Calcium Supplements (CCS) in the Management of Primary Hypoparathyroidism.
-
CLINICAL_TRIALS study record update · 2015-03-06A Randomized, Dose-blinded Study to Investigate the Safety and Efficacy of NPSP558, a Recombinant Human Parathyroid Hormone [rhPTH(1-84)], at Fixed Doses of 25 µg and 50 µg for the Treatment of Adults With Hypoparathyroidism
-
CLINICAL_TRIALS study record update · 2015-03-06A 6-Month Open-label Study Investigating the Safety and Tolerability of NPSP558, a Recombinant Human Parathyroid Hormone (rhPTH [1-84]), for the Treatment of Adults With Hypoparathyroidism - A Clinical Extension Study
-
CLINICAL_TRIALS study record update · 2015-03-06A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Investigate the Use of NPSP558, a Recombinant Human Parathyroid Hormone (rhPTH[1-84]) for the Treatment of Adults With Hypoparathyroidism
-
CLINICAL_TRIALS study record update · 2014-07-01Hypoparathyroidism, Autosomal Dominant Hypocalcaemia and Pseudohypoparathyroidism in Denmark - Epidemiology, Causes, Symptoms and Prognoses
-
CLINICAL_TRIALS study record update · 2012-10-24Treatment of Hypoparathyroidism With Subcutaneous PTH (1-84) Injections: Effects on Muscle Function and Quality of Life
-
CLINICAL_TRIALS study record update · 2012-09-14Does Treatment of Hypovitaminosis D Increase Calcium Absorption?
-
CLINICAL_TRIALS study record update · 2011-08-29Effect of Magnesium Treatment on Plasma Calcium in Hypoparathyroid Patients
-
CLINICAL_TRIALS study record update · 2009-12-25Preoperative Vitamin D Levels as a Prognostic Factor for Postoperative Hypocalcemia and Hypoparathyroidism After Total Thyroidectomy